Ingevity SVP granted 3,688 stock units

Castillo Ruth reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Castillo Ruth reported acquisition or exercise transactions in this Form 4 filing.

Ingevity Corp senior executive Ruth Castillo, SVP and President of Performance Materials, reported receiving a grant of 3,688 shares of common stock as a stock award. These restricted stock units were granted at no cash cost and will vest in three equal installments on February 27, 2027, 2028, and 2029.

Insider Trade Summary

Grant/Award: 3,688 shares

Grant/Award 1 txn

Insider Castillo Ruth

Role SVP and Pres, Perf Materials

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,688	$0.00	$0.00

Holdings After Transaction: Common Stock — 3,688 shares (Direct)

Footnotes (1)

1. F1. Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on February 27, 2027, 2028, and 2029.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ingevity Corp (NGVT) report for Ruth Castillo?

Ingevity reported that executive Ruth Castillo received a grant of 3,688 shares of common stock as restricted stock units. The award was recorded at a price of $0.00 per share and represents an equity-based compensation grant, not an open-market stock purchase or sale.

What role does Ruth Castillo hold at Ingevity Corp (NGVT)?

Ruth Castillo serves as Senior Vice President and President, Performance Materials, at Ingevity. Her Form 4 filing reflects an equity award tied to this leadership role, documenting newly granted restricted stock units rather than a discretionary market transaction in the company’s shares.

How many Ingevity (NGVT) shares were granted in the Form 4 filing?

The filing shows a grant of 3,688 shares of Ingevity common stock in the form of restricted stock units. All 3,688 shares are reported as directly owned following the transaction, reflecting the full size of this equity compensation award to the executive.

When do Ruth Castillo’s Ingevity (NGVT) restricted stock units vest?

The restricted stock units granted to Ruth Castillo will vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029. This multi-year vesting schedule aligns the award with longer-term service and performance at Ingevity.

Was cash paid for the Ingevity (NGVT) shares reported in this Form 4?

No cash was paid for these shares. The transaction is coded as a grant or award acquisition, with a reported price of $0.00 per share, indicating standard equity compensation rather than a market purchase of Ingevity common stock by the executive.

Are the Ingevity (NGVT) shares held directly or indirectly by Ruth Castillo?

The Form 4 indicates that the 3,688 shares from this award are held directly by Ruth Castillo. The ownership code is listed as direct, and there is no footnote transferring voting or investment authority to a separate trust, partnership, or similar entity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 08:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Castillo Ruth

(Last) (First) (Middle)

C/O INGEVITY CORPORATION

4920 O'HEAR AVENUE, SUITE 400

(Street)

NORTH CHARLESTON SC 29405

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and Pres, Perf Materials

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		3,688(1)	A	$0	3,688	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units pursuant to the Ingevity Corporation 2025 Omnibus Incentive Plan, which will vest in three equal installments on February 27, 2027, 2028, and 2029.

Remarks:

	Ruth Castillo By: Mavis G. Huger as Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.